Chronic inflammation, a key cancer risk factor, promotes aberrant AID expression via TNFα-NF-κB signaling in inflammation-driven cancers like H. pylori-associated gastric cancer and colitis-related colon cancer (68, 69). This evidence concerns the gene NFKB1 and cancer.